Tofacitinib De-escalation in UC: Proceed With Caution

Patients with ulcerative colitis who de-escalate tofacitinib therapy may experience a disease flare, and not all will recapture clinical response with dose re-escalation, real-world data show.
Medscape Medical News

source https://www.medscape.com/viewarticle/992245?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost